Dr Alan Duncan Robertson
Pharmaceutical
Pharmaxis
Australia
Biography
Dr Alan Duncan Robertson, BSc, PhD served at Wellcome plc in London and Faulding Ltd & Amrad Ltd in Australia for 8 years. Dr Robertson served as the Chief Executive Officer of Pharmaxis Ltd from December 1999 to March 2013. He served as Medicinal Chemist of Wellcome PLC since 1984, working on the design and synthesis of new prostaglandin compounds. Dr Robertson led a large team of medicinal chemists targeting new treatments for migraine and cardiovascular disease from which a number of important scientific discoveries were made. He served as New Product Development Manager of Faulding Group since 1992 with specific responsibilities for the global development of generic injectable drugs. He served as Head of Drug Development of Amrad Pty Ltd since 1994 and assisted in preparing Amrad for listing on the ASX.
Research Interest
CVS
